Neuberger Berman Group LLC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$585,000
-60.2%
56,228
-41.4%
0.00%
-50.0%
Q2 2019$1,471,000
+90.8%
96,000
+60.0%
0.00%
+100.0%
Q1 2019$771,000
-23.2%
60,000
-0.8%
0.00%0.0%
Q3 2018$1,004,000
+19.1%
60,500
+15.2%
0.00%0.0%
Q2 2018$843,000
-84.5%
52,500
-76.9%
0.00%
-83.3%
Q2 2013$5,430,000227,7590.01%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders